Medius Deal Watch January 2018
One key question for 2018 is whether the recent US tax changes will have an...
Read MoreThe headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Remember:
Get our executive insight into your inbox
Written By
Medius Associates
7 February 2018
One key question for 2018 is whether the recent US tax changes will have an...
Read MoreIn looking at deals each month, certain patterns start to emerge. This mon...
Read MoreFor some time now, Medius has noted that corporate acquisitions are in decl...
Read MoreOctober 2017 has proved to be a very interesting month, with our Deal Watch...
Read MoreThe trend we have noted previously in the decline in the number of pharma M...
Read MoreThere is plenty of evidence that the number and value of biopharma M&A and ...
Read MoreThe cheque books have been out in force in July, and payments were for subs...
Read MoreFollowing the scarcity of billion dollar headline deals in March, this mont...
Read MoreThe Drugs & Dealers Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.
© 2018 All Rights Reserved By Biotech and Money / LSX Limited
Add Your Response